-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster II

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Yuhua Ru1*, Jinjin Zhu2*, Huanle Gong, PhD3*, Mimi Xu, MD1*, Ying Wang4*, Miao Miao, MD5*, Suning Chen, MD, PhD6*, Xiang Zhang7*, Yi Fan8*, Yang Xu3*, Jia Chen5* and Depei Wu, MD, PhD9

1The First Affiliated Hospital of Soochow University, Suzhou, CHN
2The first affiliated hospital of Soochow University, Suzhou, China
3The First Affiliated Hospital Of Soochow University, Suzhou, China
4The First Affiliated Hospital of Soochow University, Suzhou, China
5National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
6The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China
7Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
8The First Affilliated Hospital of Soochow University, Suzhou, CHN
9Department of Hematology, the First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Suzhou, China

Lev Gorfinkel, MD1,2,3, Muna Qayed, MD4, Brandi Bratrude5*, Kayla Betz, BS6*, Kyle Hebert, MS7*, Sung W. Choi, MD, MS8, Jeffrey Davis9*, Christine Duncan10,11,12, Roger H. Giller, MD13*, Michael S. Grimley, MD14, Andrew Harris, MD15*, David A Jacobsohn, MD16, Nahal Lalefar, MD17*, Nosha Farhadfar, MD18*, Michael A. Pulsipher, MD19, Shalini Shenoy, MD20, Aleksandra Petrovic, MD21*, Kirk R. Schultz, MD22, Gregory Yanik, MD23*, Bruce R Blazar, MD24, John T. Horan, MD25, Amelia Langston, MD26, Leslie Kean, MD27 and Benjamin Watkins, MD28

1Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA
2Harvard Medical School, Boston, MA
3Dana-Farber Cancer Institute, Boston, MA
4Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
5Boston Children's Hospital, Boston
6Boston Children's Hospital, boston, MA
7Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
8Blood and Marrow Transplantation Program, University of Michigan, Ann Arbor, MI
9BC Children's Hospital, Oak Harbor, WA
10Division of Pediatric Hematology/Oncology, Boston Children’s Hospital, Boston, MA
11Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
12Department of Pediatrics, Harvard Medical School, Boston, MA
13University of Colorado SOM / Childrens Hospital Colorado, Denver, CO
14Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
15Pediatric Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
16Children's National Medical Center, Washington, DC
17UCSF Benioff Children's Hospital Oakland, Oakland, CA
18University of Florida, Gainesville, FL
19Huntsman Cancer Institute, Salt Lake City, UT
20Department of Pediatrics, Division of Hematology / Oncology, Washington University Medical Center, Saint Louis, MO
21Fred Hutchinson Cancer Center, Seattle, WA
22B.C. Children's Hospital, Vancouver, BC, Canada
23Rogel Cancer Center, University of Michigan, Ann Arbor, MI
24Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
25University of Rochester Medical Center, Rochestser
26Emory University, Winship Cancer Institute, Atlanta, GA
27Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
28Tulane University, New Orleans

Muhammad Umair Mushtaq1,2,3, Amir Kasaeian2,3*, Muhammad Kashif Amin, MD1,2,3*, Hediyeh Alemi2,3*, Naghmeh Khavandgar2,3*, Aqeeb Ur Rehman, MD2,3*, Sibgha Gull Chaudhary, MD2,3*, Matthew McGuirk2,3*, Al-Ola Abdallah, MD1,2, Anurag K. Singh, MD1,2,3, Sunil Abhyankar, MD1,2,3, Mehdi Hamadani, MD3,4, Joseph P. McGuirk, DO1,2,3 and Moazzam Shahzad, MD2,3,5

1US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
2Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
3Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
4Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
5Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL

Daniel Dexter, MBBS1*, Farah O'Boyle2*, Kirstin Lund, MRCP, BSc3*, Toni Petterson4*, Adam Gassas, MD5*, Leena Karnik, FRCPath, MRCP6*, Josu de la Fuente, PhD FRCP7,8,9, Sandrine Bremathas, RN10* and Kelly Hennessy11*

1Department of Haematology, Kings College Hospital, London, ENG, United Kingdom
2Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
3St Marys Hospital, Imperial College NHS FoundationTrust, London, United Kingdom
4St Marys Hospital, Imperial College NHS Foundation Trust London, London, GBR
5St Marys Hospital, Imperial College NHS Foundation Trust, London, United Kingdom
6St Marys Hospital, Imperial College NHS Foundation Trust, London, GBR
7Department of Paediatrics, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
8Division of Immunology and Inflammation, Imperial College London, London, United Kingdom
9Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom
10IMPERIAL COLLEGE HEALTHCARE NHS TRUST, London, United Kingdom
11St Marys Hospital, Imperial College London, London, United Kingdom

Irwin Walker, MBBS1,2, Uday Deotare, MBBS, MD, MScHQ3,4,5*, Mohamed Elemary, MD, MSc, PhD6*, Mahmoud Elsawy, MD, MSc7,8*, Genevieve Gallagher, MD9*, David Kliman, MBBS, FRACP, FRCPA10*, Tony Panzarella, MSc11*, Nada Hamad, MBBS, MSc, BSc12,13,14, Kirk R. Schultz, MD15,16, Jan Storek, MD, PhD17 and Kristjan Paulson, MD18

1Department of Medicine, McMaster University, Hamilton, ON, Canada
2Juravinski Cancer Centre, Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada
3Princess Margaret Cancer Centre, Toronto, ON, CAN
4Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada
5Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada
6Provincial Hematology and Blood and Marrow Transplant Program, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK, Canada
7Dalhousie University, Halifax, NS, Canada
8QEII Health Sciences Center, Halifax, NS, Canada
9Centre intégré de cancérologie, CHU de Québec - Université Laval, Québec, QC, Canada
10GenesisCare North Shore, St Leonards, NSW, Australia
11University of Toronto, Toronto, ON, CAN
12St Vincent's Hospital, Sydney, NSW, Australia
13Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
14The University of New South Wales, Kensington, NSW, Australia
15University of British Columbia, Vancouver, BC, Canada
16B.C. Children's Hospital, Vancouver, BC, Canada
17The University of Calgary Department of Medicine, Calgary, Canada
18Cancercare Manitoba, Winnipeg, MB, Canada

Antonio Bianchessi1,2*, Irene Defrancesco1,3*, Virginia Valeria Ferretti4*, Cristina Picone5*, Beatrice Ferrari5*, Caterina Zerbi1*, Francesco Romano1,2*, Giulia Losi, MD1,2*, Erica Consensi5*, Mara De Amici6*, Giorgia Testa7*, Valentina Zoboli1*, Alessia Taurino1*, Anna Amelia Colombo1*, Luca Arcaini1,2* and Nicola Polverelli1

1Unit of Bone Marrow Transplantation - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
2Department of Molecular Medicine, University of Pavia, Pavia, Italy
3Deparment of Surgical, Clinical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy
4Unit of Biostatistics and Clinical Trial Center, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
5Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
6Immuno-Allergology Laboratory of the Clinical Chemistry Unit and Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, ITA
7Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Joseph Rimando, MD1, Michel Conn1*, William Blum, MD1, Jason T Romancik, MD2, Colin Vale, MD3*, Amelia Langston, MD1, Edmund K. Waller, MD, PhD1 and Kevin Hall, PharmD1*

1Emory University, Winship Cancer Institute, Atlanta, GA
2Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
3Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

Jingbo Yu, MD, PhD1*, Kristin J. Moore, PhD, MPH2*, Nicole M. Engel-Nitz, PhD, MS2*, Mary DuCharme, MLIS2*, Britnie Thomas, PhD1*, John Galvin, MD, MPH3 and Valkal Bhatt, PharmD1*

1Incyte Corporation, Wilmington, DE
2Optum, Eden Prairie, MN
3Senior Medical Director, Incyte Corporation, Wilmington, DE

Xinghao Yu1,2*, Yiyin Chen1,2*, Lei Lei1,2*, Dandan Lin1,2*, Ying Shen1,2*, Chang Hou1,2*, Jia Chen1*, Yi Fan1*, Huimin Lu3*, Depei Wu, MD, PhD2,4 and Yang Xu, MD1,2*

1National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
2Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
3Department of outpatient and emergency, The First Affiliated Hospital of Soochow University, Suzhou, China
4The First Affiliated Hospital of Soochow University, Suzhou, China

Sibgha Gull Chaudhary, MD1,2,3*, Moazzam Shahzad, MD1,4, Kayla Pfannenstiell3*, Muhammad Kashif Amin, MD1,2,3*, Amir Kasaeian1,3*, Muhammad Fareed Khalid, MD1,3*, Hediyeh Alemi1,3*, Naghmeh Khavandgar1,3*, Iqra Anwar, MBBS1,3*, Matthew McGuirk1,3*, Syed Nasir Abbas Bukhari1,3*, Anurag K. Singh, MD1,2,3, Mehdi Hamadani, MD1,5, Joseph P. McGuirk, DO1,2,3 and Muhammad Umair Mushtaq1,2,3

1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
4Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
5Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Alice Bertaina, MD, PhD1,2,3, Rosa Bacchetta, MD1,2,3*, Alma-Martina Cepika, MD, PhD1,2*, David C Shyr, MD1,2,3, Giulia Barbarito, MS1,2*, Linda Oppizzi, BS1,2*, Pauline Chen, MD1,2*, Gopin Saini, MBBS1,2*, Jennifer Lee, PhD1,2*, Karen Kristovich, RN PNP1,3*, Rajni Agarwal, MD2,4,5*, Orly Klein, MD1,2,3, Kathryn Melsop, MS2,6*, Keri Tate, PhD2,6*, Matthew Porteus, MD, PhD1,2,3 and Maria Grazia Roncarolo, MD1,2,3

1Department of Pediatrics/ Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
2Center for Definitive and Curative Medicine, Stanford University School of Medicine, Stanford, CA
3Lucile Packard Children’s Hospital, Palo Alto, CA
4Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
5Lucile Packard Children’s Hospital, Palo Alto
6Laboratory for Cell and Gene Medicine, Stanford University School of Medicine, Palo Alto, CA

Rory McFarland, MD Candidate1*, Rida Hasan, MD1 and Sandhya R. Panch, MD2,3

1University of Washington, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3Fred Hutchinson Cancer Center, Seattle

Elisabeth Dovern, MD1*, Tim R. Mocking2,3*, Mette D. Hazenberg, MD, PhD4,5*, Arjan A. van de Loosdrecht, MD, PhD2,6*, Simon Tol7*, Erik Mul8*, Boukje M. Beuger7*, Robin Van Bruggen, PhD7*, Myrddin Verheij, PhD3,9*, Carlijn Voermans, PhD3,9*, Costa Bachas, PhD2,3*, Bart J. Biemond1 and Erfan Nur, MD, PhD1,10

1Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
3Department of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands
4Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
5Sanquin Research, Amsterdam, Netherlands
6Department of Hematology, Amsterdam University Medical Center, Free University, Amsterdam, Netherlands
7Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
8Department of Research Facilities, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
9Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
10Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands

Scott R. Solomon, MD1, Melissa Sanacore, PharmD1*, Lizamarie Bachier Rodriguez, MD1, Latasha McCoy1*, Caitlin Guzowski, MBA1*, Katelin C Jackson1*, Xu Zhang, PhD2*, H. Kent Holland, MD1*, Lawrence E Morris, MD1, Melhem M. Solh, MD1 and Asad Bashey, MD, PhD1

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
2Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX

Victor Ling Wei Teik1*, Yeh Ching Linn2*, Huirong Han1*, Michelle Poon, MBBS, MRCP1*, Lip Kun Tan1*, Joanne Shu Xian Lee1*, Yang Liang Boo, MD, MRCP1*, Ian Wu, MBBS, MRCP, MD1*, Jean Rachel Catapia, MD1*, Aloysius Yew Leng Ho2, William Ying Khee Hwang2, Yeow Tee Goh, MD2, Francesca Lim, MBBS2*, Hein Than, MD, FRCPath, MRCP2, Lawrence Cheng Kiat Ng, MD2*, Jeffrey Kim Siang Quek2*, Tertius Tansloan Tuy, MD, MRCP(UK)2*, Balamurugan Vellayappan3*, Zi Yi Lim, MBBS, FRCP, FRCPath4*, Colin Phipps Diong, MD5*, Yvonne Loh6*, Kheng Wei Yeoh7*, Brian Ho7*, Wen Shen Looi7*, Yin Jie Koh1*, Teck Guan Soh1*, Kee Khiang Heng8*, Gina Gan8*, Wing Leung, PhD, MD9 and Liang Piu Koh1*

1Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
2Department of Haematology, Singapore General Hospital, Singapore, Singapore
3Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore
4Centre for Clinical Haematology, Mount Elizabeth Novena Hospital, Singapore, Singapore
5Parkway Cancer Centre, Mount Elizabeth Hospital, Singapore, Singapore
6Curie Oncology, Singapore, Singapore
7Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore
8Singapore General Hospital, Singapore, Singapore
9KK Women’s and Children’s Hospital, Duke-NUS, Singapore, Singapore

Udit Nangia, MD1, Leland Metheny, MD2 and Neeraj Mahajan, MD3*

1University Hospitals - Parma Medical Center, Vernon Hills, IL
2Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
3University Hospitals - Parma Medical Center, Parma, OH

Maria Carmen Martinez Munoz, MD, PhD1*, Leyre Bento De Miguel2*, Maria Queralt Salas3*, Juan Montoro4*, Jaime Sanz5*, Lucia Lopez Corral, MD6*, Estefanía Pérez López, MD6*, Maria Jesús Pascual, MD7*, Irene García-Cadenas, MD8*, Maria Suarez-Lledo, MD, PhD9,10*, Arancha Bermúdez11*, Felipe Peña, MD12*, Carlos Carretero13*, María-José Jiménez Lorenzo14*, Pedro Antonio González15*, Antonia Sampol Mayol16*, Inmaculada Heras, MD17*, Teresa Zudaire18*, Pascual Balsalobre19*, Silvia Filaferro19*, Angel Cedillo20*, Carlos Solano, MD, PhD21,22 and Manuel Jurado Chacón23*

1Hematopoietic Cell Transplant Unit, Hospital Clinic of Barcelona, ICAMS, Barcelona, Spain
2Hematology Department, Son Espases University Hospital, IdISBa, Palma, Spain
3Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICAMS, Barcelona, Spain
4Hematology Department, Hospital La Fe, Valencia, Spain
5Hematology Department, Hospital Universitari i Politècnic La Fe, Departament de Medicina Universitat de Valencia, CIBERONC, Instituto Carlos III, Spain, VALENCIA, Spain
6Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
7Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain
8Hematology Departmen, Hospital de Sant Pau, Barcelona, Spain
9Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Spain, Hospital Clínic de Barcelona, Barcelona, Spain
10Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
11Hospital Marques de Valdecilla (IDIVAL), Santander, Spain
12Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
13Hematology Department, Hospital Universitario Masqués de Valdecilla, Santander, Spain
14Hematology Department, Institut Català d’Oncologia de Badalona, Hospital Universitari Germans Trias i Pujol. Institut d’Investigació contra la Leucèmia Josep Carreras. Universitat Autònoma de Barcelona, Badalona, Spain
15Hematology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain
16Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain
17Hematology Division, Hospital Morales Meseguer, Murcia, Spain
18Hematology Department, Complejo Hospitalario de Navarra, Pamplona, ESP
19Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC) Data Office, Madrid, Spain
20GETH Data Office, Madrid, Spain
21University of Valencia, Valencia, Spain
22Hematology Department, Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
23Hospital Univ. Virgen de las Nieves, Granada, Spain

Rahul Ramaswamy, MD1*, Laith Fakhoury, BS1*, Peter Zhao, MD1*, Ningying Wu, MD, PhD2*, Feng Gao3*, Geoffrey L. Uy, MD4, John F. DiPersio, MD, PhD5 and Zachary D. Crees, MD5

1Washington University School of Medicine, St. Louis, MO
2Public Health Sciences Division, Washington University School of Medicine, St Louis, MO
3Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, Saint Louis, MO
4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
5Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Yaqun Hong1,2*, Min Xu1,2*, Yuanzhong Chen2*, Nainong Li, MD, PhD1,3 and Xiaofan Li, MD, PhD2,4

1Fujian Medical University, Fuzhou, China
2Fujian Medical University Union Hospital, Fuzhou, China
3Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China
4Union Clinical Medical Colleges, Fujian Medical University, Fuzhou, China

Tamer Othman, MD1, Dongyun Yang, PhD2*, Sally Mokhtari, PhD3, Ibrahim Aldoss, MD4, Geoffrey Shouse, PhD, DO5, Shukaib Arslan, MD6*, Leonardo Farol7*, Leslie L. Popplewell, MD, MPH8, Ahmed Aribi, MD9*, Alex F. Herrera, MD10, Lihua E. Budde, MD, PhD11, Joshua Mansour, MD6*, Matthew Mei, MD5, Karamjeet S Sandhu, MD4, Tanya Siddiqi, MD, MBBS12*, Jasmine Zain, MD10, Vaibhav Agrawal, M.D.4, Idoroenyi Amanam, MD6, Vinod Pullarkat, MD13, Tycel J. Phillips, MD14, Ryotaro Nakamura, MD6, Stephen J. Forman, MD, FACP15 and Monzr M. Al Malki, MD10

1Hematology/HCT, City of Hope, San Lorenzo, CA
2Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
3Clinical and Translational Project Development, City of Hope National Medical Center, Duarte, CA
4Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
5City of Hope Cancer Center, Duarte, CA
6Hematology and HCT, City of Hope National Medical Center, Duarte, CA
7City of Hope, Daurte, CA
8City of Hope Cancer Treatment Center, Atlanta, GA
9Hematology/HCT, City of Hope National Medical Center, Duarte, CA
10City of Hope, Duarte, CA
11Department of Hematology and HCT, City of Hope, Duarte, CA
12City of Hope National Medical Center, Duarte, CA
13City of Hope, La Canada, CA
14City of Hope, Pasadena, CA
15Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

Yin Liu*, Ye Zhao*, Xiaofei Qi*, Qiao Cheng*, Jia Chen*, Xiao Ma*, Shengli Xue*, Ying Wang*, Xiaowen Tang*, Huiying Qiu*, Yang Xu, MD* and Depei Wu

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

Marjia Afrin, Ph.D.1*, Sahar Nasr1*, Cristabelle De Souza2*, Brooke Howitt, MD, PhD3*, Antonia Maria Mueller, MD4, Sally Arai, MD5, Judith Shizuru1* and Gerlinde Wernig, MD6*

1Stanford University, Stanford, CA
2Stanford, Stanford, CA
3Department of Pathology, Stanford University, Stanford, CA
4General Hospital Vienna, Vienna, Austria
5Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
6Stanford Hospital & Clinics, Stanford, CA

Li Nannan, MD1*, Yue Lu2*, Deyan Liu2*, Min Xiong3*, Yanli Zhao2,3*, Ruijuan Sun3,4*, Zhijie Wei2,3*, Xingyu Cao2,3*, Jiarui Zhou2,3*, Jianping Zhang2,3* and Peihua Lu, MD2,3,5

1Hospital, Yanjiao Economic and Technological Devel, AL, CHN
2Hebei Yanda Lu Daopei Hospital, Langfang, China
3Beijing Lu Daopei Hospital, Beijing, China
4Hebei Yanda Lu Daopei Hospital, Beijing, China
5Beijing Lu Daopei Institute of Hematology, Beijing, China

*signifies non-member of ASH